HT
TGTX icon

HAP Trading’s TG Therapeutics TGTX Stock Holding History

HAP Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,120
Closed -$279K – 2758
2021
Q4 		$458K Sell
24,120
-17,899
-43% -$465K 0.01% 714
2021
Q3 		$1.4M Buy
42,019
+8,824
+27% +$273K 0.05% 370
2021
Q2 		$1.29M Buy
+33,195
New +$1.3M 0.04% 382
2016
Q2 		– Sell
-33,609
Closed -$286K – 1042
2016
Q1 		$286K Sell
33,609
-3,141
-9% -$27.5K 0.02% 362
2015
Q4 		$438K Sell
36,750
-13,576
-27% -$171K 0.02% 399
2015
Q3 		$507K Buy
50,326
+4,443
+10% +$66.2K 0.03% 368
2015
Q2 		$761K Buy
45,883
+14,301
+45% +$226K 0.05% 299
2015
Q1 		$489K Buy
+31,582
New +$478K 0.03% 343

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

HAP Trading's TGTX Position: Q1 2022 in Review

HAP Trading sold out of TG Therapeutics (TGTX) in Q1 2022, closing a stake of 24,120 shares — an estimated $279K sold.

HAP Trading first reported a position in TGTX in Q1 2015 and held it in 8 quarters. The position peaked at $1.4M in Q3 2021. 181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

  • HAP Trading reported no remaining TG Therapeutics position as of Q1 2022 after selling out during the quarter.
  • HAP Trading sold 24,120 TG Therapeutics shares in Q1 2022, an estimated $279K.
  • HAP Trading first reported a position in TG Therapeutics in Q1 2015 and held it in 8 quarters.
  • HAP Trading's TG Therapeutics position peaked at $1.4M in Q3 2021.
  • 181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.